Inspired by her mother, Vicky Qi leads drug discovery teams.

When a middle-aged firefighter and active Boy Scout leader in the Midwestern United States lost his hearing a few years ago, he also faced the loss of his livelihood.

NIBR investigator develops technology that uses tumor DNA in the blood for diagnostics

Novartis CEO Vas Narasimhan answers questions about COVID-19.

Novartis has been at the forefront of advances in how blood cancers and serious blood disorders are treated, helping patients live their best lives.

Combination of two compounds shows promise in the lab

Building on more than two decades of chronic myeloid leukemia research, the R&D teams at Novartis pursued an investigational treatment unlike any other.